Stryker Corporation Website

Stryker Corporation

NYSE-SYK

Basic

  • Market Cap

    $124.77B

  • EV

    $133.17B

  • Shares Out

    380.26M

  • Revenue

    $20.96B

  • Employees

    52,000

Margins

  • Gross

    63.99%

  • EBITDA

    26.17%

  • Operating

    21.25%

  • Pre-Tax

    18.69%

  • Net

    16.03%

  • FCF

    13.63%

Returns (5Yr Avg)

  • ROA

    7.34%

  • ROTA

    26.85%

  • ROE

    16.8%

  • ROCE

    12.6%

  • ROIC

    12.43%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $371.92

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $2,407M

  • Net Debt

    $8,400M

  • Debt/Equity

    0.56

  • EBIT/Interest

    12.51

Growth (CAGR)

  • Rev 3Yr

    12.52%

  • Rev 5Yr

    8.6%

  • Rev 10Yr

    8.66%

  • Dil EPS 3Yr

    33.39%

  • Dil EPS 5Yr

    -1.14%

  • Dil EPS 10Yr

    15.81%

  • Rev Fwd 2Yr

    7.83%

  • EBITDA Fwd 2Yr

    11.44%

  • EPS Fwd 2Yr

    11.73%

  • EPS LT Growth Est

    9.79%

Dividends

  • Yield

  • Payout

    26%

  • DPS

    $2.3

  • DPS Growth 3Yr

    -1.55%

  • DPS Growth 5Yr

    3.04%

  • DPS Growth 10Yr

    7.27%

  • DPS Growth Fwd 2Yr

    8.2%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Total Revenues

14,884

14,351

17,108

18,449

20,498

20,963

Total Revenues % Chg.

9.4%

-3.6%

19.2%

7.8%

11.1%

10.6%

Cost of Goods Sold, Total

5,083

5,193

5,846

6,803

7,401

7,549

Gross Profit

9,801

9,158

11,262

11,646

13,097

13,414

Selling General & Admin Expenses, Total

4,968

4,759

5,752

6,114

6,943

7,002

R&D Expenses

971

984

1,235

1,454

1,301

1,330

Amortization of Goodwill and Intangible Assets

464

472

619

627

635

627

Other Operating Expenses, Total

6,403

6,215

7,606

8,195

8,879

8,959

Operating Income

3,398

2,943

3,656

3,451

4,218

4,455

Interest Expense, Total

-287

-315

-337

-337

-356

-356

Interest And Investment Income

155

102

15

25

75

75

Net Interest Expenses

-132

-213

-322

-312

-281

-281

Currency Exchange Gains (Loss)

7

15

43

69

59

59

Other Non Operating Income (Expenses)

-18

-64

-11

88

7

14

EBT, Excl. Unusual Items

3,255

2,681

3,366

3,296

4,003

4,247

Restructuring Charges

-226

-459

-397

-262

-292

-292

Merger & Related Restructuring Charges

-275

-242

-585

-150

-20

-20

Impairment of Goodwill

-216

Legal Settlements

Other Unusual Items

-192

-26

-103

15

-18

-18

EBT, Incl. Unusual Items

2,562

1,954

2,281

2,683

3,673

3,917

Income Tax Expense

479

355

287

325

508

556

Earnings From Continuing Operations

2,083

1,599

1,994

2,358

3,165

3,361

Net Income

2,083

1,599

1,994

2,358

3,165

3,361

Net Income to Common Incl Extra Items

2,083

1,599

1,994

2,358

3,165

3,361

Net Income to Common Excl. Extra Items

2,083

1,599

1,994

2,358

3,165

3,361

Total Shares Outstanding

374.5

376.1

377.5

378.7

380.1

380.4

Weighted Avg. Shares Outstanding

374

375.5

377

378.2

379.6

380

Weighted Avg. Shares Outstanding Dil

379.9

380.3

382.3

382.2

383.7

384.2

EPS

5.6

4.3

5.3

6.2

8.3

8.8

EPS Diluted

5.5

4.2

5.2

6.2

8.3

8.8

EBITDA

4,176

3,755

4,646

4,449

5,246

5,486

Effective Tax Rate

18.7%

18.2%

12.6%

12.1%

13.8%

14.2%